Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
Casadei Gardini A, Conti F, Foschi FG, Brillanti S, Andreone P; members of Bologna DAA group. Casadei Gardini A, et al. Gastroenterology. 2018 Jun;154(8):2281-2282. doi: 10.1053/j.gastro.2017.12.051. Epub 2018 May 7. Gastroenterology. 2018. PMID: 29746809 Free article. No abstract available.
High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
Berardi S, Lodato F, Gramenzi A, D'Errico A, Lenzi M, Bontadini A, Morelli MC, Tamè MR, Piscaglia F, Biselli M, Sama C, Mazzella G, Pinna AD, Grazi G, Bernardi M, Andreone P. Berardi S, et al. Gut. 2007 Feb;56(2):237-42. doi: 10.1136/gut.2006.092064. Epub 2006 Jun 23. Gut. 2007. PMID: 16798778 Free PMC article.
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.
Lodato F, Berardi S, Gramenzi A, Mazzella G, Lenzi M, Morelli MC, Tame MR, Piscaglia F, Andreone P; Bologna Liver Transplantation Group (BLTG); Ballardini G, Bernardi M, Bianchi FB, Biselli M, Bolondi L, Cescon M, Colecchia A, D'Errico A, Del Gaudio M, Ercolani G, Grazi GL, Grigioni W, Lorenzini S, Pinna AD, Ravaioli M, Roda E, Sama C, Vivarelli M. Lodato F, et al. Among authors: berardi s. Aliment Pharmacol Ther. 2008 Aug 15;28(4):450-7. doi: 10.1111/j.1365-2036.2008.03761.x. Epub 2008 Jun 11. Aliment Pharmacol Ther. 2008. PMID: 18549463 Clinical Trial.
Routine blood tests? Helping you live(r) longer!
Berardi S, Berzigotti A, Cappelli A, Mastroroberto M, Serra C, D'Errico A, Russo V, Garcia-Criado A, Sama C. Berardi S, et al. Lancet. 2011 Dec 10;378(9808):2048. doi: 10.1016/S0140-6736(11)61456-6. Lancet. 2011. PMID: 22153201 No abstract available.
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.
Golfieri R, Giampalma E, Renzulli M, Cioni R, Bargellini I, Bartolozzi C, Breatta AD, Gandini G, Nani R, Gasparini D, Cucchetti A, Bolondi L, Trevisani F; PRECISION ITALIA STUDY GROUP. Golfieri R, et al. Br J Cancer. 2014 Jul 15;111(2):255-64. doi: 10.1038/bjc.2014.199. Epub 2014 Jun 17. Br J Cancer. 2014. PMID: 24937669 Free PMC article. Clinical Trial.
151 results